As Trump prepares plan to lower drug prices, big pharma girds for a fight


Big Pharma is pouring money into a lobbying campaign to thwart any serious efforts to rein in prescription drug prices before a presidential speech this month where Trump plans to lay out his drug pricing proposals. "There is apprehension across the industry," said Bruce Artim, who retired recently after 11 years as the director of federal affairs at Eli Lilly and Co.



from Biotech News